Honkavaara P, Saarnivaara L
Department of Anaesthesia, Otolaryngological Clinic, Helsinki University Central Hospital, Finland.
Acta Anaesthesiol Scand. 1998 Feb;42(2):211-5. doi: 10.1111/j.1399-6576.1998.tb05111.x.
Middle ear surgery is associated with a high incidence of emetic sequelae and propofol has been reported to have antiemetic activity in subhypnotic doses.
In a double-blind, randomized study, the patients received either thiopentone 1.0 mg.kg-1 (n = 26) or 0.5 mg.kg-1 propofol (n = 26) at the end of middle ear surgery under isoflurane-N2O-fentanyl-vecuronium anaesthesia. Trained nurses, unaware of the group assignment, assessed postoperative nausea, retching and vomiting up to 24 h after the end of anaesthesia. Droperidol 10 micrograms.kg-1 was used as a "rescue" antiemetic.
The main result was that the patient in the propofol group did not suffer from retching and vomiting (R&V) during the first 6 h, whereas these symptoms occurred in 46% (P < 0.001) of the patients in the thiopentone group. The patients in the propofol group needed significantly less droperidol during the first 24 h (mean number of doses 0.39 +/- 0.57 (SD)) than the patients in the thiopentone group (1.35 +/- 1.47, P < 0.005). Treatment with propofol was a predictor for lowered incidence of R&V, as well as male gender and negative history of motion sickness.
Propofol at a subhypnotic dose of 0.5 mg.kg-1 provides prophylaxis against retching and vomiting for the first 6 h postoperatively after middle ear surgery. The incidence of nausea was not reduced by propofol.
中耳手术与呕吐后遗症的高发生率相关,据报道丙泊酚在亚催眠剂量时有抗呕吐活性。
在一项双盲、随机研究中,患者在异氟烷-氧化亚氮-芬太尼-维库溴铵麻醉下中耳手术结束时,接受硫喷妥钠1.0mg·kg-1(n = 26)或0.5mg·kg-1丙泊酚(n = 26)。不知情分组情况的经过培训的护士评估麻醉结束后长达24小时的术后恶心、干呕和呕吐情况。氟哌利多10μg·kg-1用作“解救”性止吐药。
主要结果是丙泊酚组患者在最初6小时内未出现干呕和呕吐(R&V),而硫喷妥钠组46%(P < 0.001)的患者出现了这些症状。丙泊酚组患者在最初24小时内需要的氟哌利多明显少于硫喷妥钠组患者(平均剂量数0.39±0.57(标准差))(1.35±1.47,P < 0.005)。丙泊酚治疗是R&V发生率降低的一个预测因素,以及男性性别和晕动病阴性病史也是。
0.5mg·kg-1的亚催眠剂量丙泊酚可预防中耳手术后术后最初6小时的干呕和呕吐。丙泊酚未降低恶心的发生率。